Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00332605
Status:
COMPLETED
Last Update Posted:
2022-08-23
First Post:
2006-05-30
Brief Title:
N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence
Sponsor:
University of Chicago
Organization:
University of Chicago
Study Overview
Official Title:
A Double-Blind Study of N-Acetyl Cysteine Plus Naltrexone in the Treatment of Methamphetamine Dependence
Status:
COMPLETED
Status Verified Date:
2022-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of the proposed study is to evaluate the efficacy and safety of N-Acetyl Cysteine NAC in combination with naltrexone in methamphetamine dependence
Detailed Description:
Forty subjects with DSM-IV methamphetamine dependence will receive 8 weeks of double-blind combination medication NAC plus naltrexone or placebo The hypothesis to be tested is that NAC plus naltrexone will be effective and well tolerated in patients with methamphetamine dependence compared to placebo The proposed study will provide needed data on the treatment of a public health crisis that currently lacks a clearly effective treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None